Mahamaya Lifesciences Limited – IPO Launch Announcement & Key Highlights

We’re pleased to announce that Mahamaya Lifesciences Limited is launching its Initial Public Offering. With a market-leading presence in agrochemicals, plant-nutrition and crop-protection products, this is an exciting step in our growth journey.

Key Highlights

• Total Issue Size: 61,78,800 shares (aggregating up to ₹70.44 Cr)
• Fresh Issue: 53,29,200 shares (aggregating up to ₹60.75 Cr)
• Offer-for-Sale: 5,40,000 shares of ₹10 (aggregating up to ₹6.16 Cr)
• Price Band: ₹108 to ₹114 per share (Face value ₹10)
• Lot Size: 1,200 shares
• Retail Minimum Investment: ₹2,73,600 (2 lots)
• Issue Window: Opens 11 November 2025 → Closes 13 November 2025
• Allotment & Listing: Expected allotment on 14 November 2025; Tentative listing on 18 November 2025
• BRLM: Oneview Corporate Advisors Pvt. Ltd. | Registrar: KFin Technologies Ltd. | Market Maker: Mansi Share & Stock Broking Pvt. Ltd.

Strategic Use of IPO Proceeds

• Expansion of manufacturing capacity and technical-plant setup
• Construction of dedicated warehouse & purchase of machinery
• Working capital funding to fuel growth in domestic & export markets
• Strengthening R&D and agile delivery of crop-solutions

We are extremely thankful for the support of our customers, suppliers, employees, and all stakeholders who are part of this journey. We look forward to creating value together as we scale to the next level.